Abstract
Advent of regenerative medicine has opened new therapeutic interventions for patients with cardiovascular diseases The stem cell based cardiac repairing and regeneration along with improved vascularisation can improve diseased heart Clinical studies over last decade have evaluated the cardiogenic potential of embryonic induced pluripotent cardiac mesenchymal and bone marrow derived stem cells The clinical studies have raised the hope of successful translation of regenerative cells from bench to bed side Intrinsic factors guiding the stem cells to site of injury i e homing transformation into cardiomyocytes and angiogenesis have been assessed in recent years However complete understanding of mechanisms co relating and regulating the process need to be explored This review focuses on characteristics of stem cells under investigations for clinical trials analyzing safety feasibility efficacy and mechanism underlying cardio protective and cardio regenerative process Further the approaches involving scaffold based dimensional cardiac generation will also be analysed nbsp
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
